Skip to main content
Sanofi charged with Manslaughter over birth defects linked to its epilepsy drug Depakine - Medical Dialogues 05-Aug-2020
Sanofi charged with Manslaughter over birth defects linked to its epilepsy drug Depakine - Medical Dialogues
The charges relate to the drug valproate, marketed as Depakine among other trade names, which...
More...